Welcome to the Healthcare Innovation Conference Season!
Nanobiotix Making Waves at Multiple Conferences
PARIS and CAMBRIDGE, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company”), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at three upcoming conferences:
First up, we have the Guggenheim’s Inaugural Healthcare Innovation Conference on Monday, November 11, 2024, at 4pm ET / 10pm CET in Boston, MA. Presenters will include Laurent Levy, Chief Executive Officer of Nanobiotix, and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix.
Next, mark your calendars for the Stifel Healthcare Conference on Monday, November 18, 2024, at 4:45pm ET / 10:45pm CET in New York, NY. Bart van Rhijn will be the sole presenter representing Nanobiotix.
Finally, don’t miss out on the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 1pm GMT / 8am ET / 2pm CET in London, UK. Presenters at this event will once again include Laurent Levy and Bart van Rhijn from Nanobiotix.
For those unable to attend in person, the fireside chats will be webcast live from the events page of the Investors section of the Company’s website. Stay tuned for exciting updates and insights from these conferences!
How will this impact me?
As a patient, the participation of Nanobiotix in these prestigious healthcare conferences signals their commitment to advancing innovative treatments for cancer and other diseases. Stay informed about the latest developments to potentially benefit from their groundbreaking approaches in the future.
How will this impact the world?
Nanobiotix’s presence at these conferences highlights the global importance of healthcare innovation and collaboration in addressing major diseases. Their pioneering nanoparticle-based approaches have the potential to revolutionize treatment possibilities and make a significant impact on the healthcare industry worldwide.
Conclusion
Exciting times lie ahead as Nanobiotix takes center stage at the upcoming healthcare conferences. Stay tuned for valuable insights and updates that could shape the future of cancer treatment and healthcare innovation on a global scale.
